Skip to main content

Test Price

2,800 AED

✅ Home Collection Available

CACNA1D Gene Sequencing Test (Sinoatrial Node Dysfunction & Deafness) in UAE | 2800 AED | 2026 DHA Guidelines

تحليل جين CACNA1D (خلل العقدة الجيبية والصمم) في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي

Executive Summary

  • Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited NGS Processing.
  • Premium Logistics: Hospital-Grade Home Collection (8 AM – 11 PM) with ISO Certified Cold-Chain Transport & VIP Mobile Phlebotomy.
  • Clinical Guidance: Telephonic Post-Test Clinical Guidance with DHA-licensed cardiologists and genetic counsellors.
  • Insurance: Direct Billing Verification via WhatsApp at +971 54 548 8731.

يقدم هذا الاختبار تحليلًا جينيًا شاملًا لجين CACNA1D باستخدام تقنية التسلسل من الجيل التالي، مع دقة تشخيصية تصل إلى 99.9% وإرشادات سريرية بعد الفحص.

Overview

This next‑generation sequencing (NGS) test analyses the entire CACNA1D gene for pathogenic variants linked to sinoatrial node dysfunction and deafness (SANDD). Designed for patients with unexplained bradycardia, sick sinus syndrome, or progressive sensorineural hearing loss, it pinpoints the genetic cause to guide personalised cardiac and audiological management.

Feature Our Test (NGS) Closest Alternative (Sanger)
Methodology High‑throughput NGS, full gene coding + deep intronic regions Exon‑by‑exon Sanger sequencing
Turnaround Time 3 to 4 Weeks 6 to 8 Weeks
Sensitivity 99.9% for single nucleotide variants & small indels ~95% (misses deep intronic mutations)
Price 2800 AED 3500 AED

Physician Insight & Safety Protocol

“As a cardiologist with extensive experience in inherited arrhythmias, I remind patients that a positive genetic result must be correlated with clinical findings – not every variant guarantees disease, and treatment decisions should never rely on genetics alone. For families affected by sinoatrial node dysfunction and deafness, this test provides the molecular diagnosis that enables targeted surveillance and early intervention. While waiting for results, it is critical to continue prescribed therapies for heart rhythm or hearing loss, unless your doctor advises otherwise.”

— Dr. PRABHAKAR REDDY, Senior Consultant Cardiologist, DHA License 61713011

Medication Warning:

Do not discontinue prescribed medications (e.g., antiarrhythmics, hearing aids, beta‑blockers) without consulting your treating physician. Abrupt cessation may worsen symptoms.

Exclusion Criteria & Safety Red Flags

Before Sample Collection

  • Severe anaemia (Hb < 7 g/dL) or active bleeding disorder
  • Uncontrolled coagulopathy or INR > 3.0
  • Recent major surgery (< 72 hours) without haematologist clearance

Emergency Red Flags (seek urgent care)

  • Syncope or near‑syncope with bradycardia
  • Chest pain, dyspnoea, or severe dizziness
  • Sudden loss of hearing accompanied by vertigo

Patient FAQ & Clinical Guidance

What is the CACNA1D gene test and why is it prescribed?

This genetic test uses next-generation sequencing to identify mutations in the CACNA1D gene that cause sinoatrial node dysfunction and progressive deafness, enabling precise clinical management.

ما هو اختبار جين CACNA1D ولماذا يوصف؟

يستخدم هذا الاختبار الجيني تقنية التسلسل من الجيل التالي لتحديد الطفرات في جين CACNA1D المسببة لخلل العقدة الجيبية والصمم التدريجي، مما يتيح إدارة سريرية دقيقة.

How is the sample collected for this test?

A certified phlebotomist collects a small blood sample or a finger‑prick drop on an FTA card during a scheduled home visit, ensuring minimal discomfort.

كيف يتم جمع العينة لهذا الاختبار؟

يقوم أخصائي سحب دم معتمد بجمع عينة دم صغيرة أو قطرة دم على بطاقة FTA خلال زيارة منزلية مجدولة، مما يضمن أدنى انزعاج.

When will I receive my results, and how?

Results are issued within 3 to 4 weeks, accompanied by a telephonic post‑test consultation with a DHA‑licensed cardiologist or genetic counsellor to explain the findings.

متى سأحصل على نتائجي، وكيف؟

تصدر النتائج في غضون 3 إلى 4 أسابيع، مصحوبة باستشارة هاتفية بعد الفحص مع طبيب قلب أو مستشار وراثي مرخص من هيئة الصحة بدبي لشرح النتائج.

UAE Regulatory Compliance & Accreditation

  • Licensed by Ministry of Health & Prevention (MOHAP) – Facility License: 9834453
  • Compliant with Federal Decree‑Law No. 41 of 2024 (Art. 87), CDS Law 2026 (Minors), and UAE PDPL data privacy standards
  • ISO 9001:2015 Certified Quality Management System (Cert: INT/EGQ/2509DA/3139)
  • All genetic testing requires a pre‑ counselling session to draw a family pedigree and confirm clinical history of sinoatrial node dysfunction and deafness

Contact & Support: +971 54 548 8731 (Phone & WhatsApp)

دعم ثنائي اللغة متاح

التحقق من التغطية التأمينية

Check Insurance Coverage Instantly

Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.

توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.

✅ DHA Certified ✅ ISO 15189 ✅ HIPAA Compliant

Available in Arabic, English, Hindi & Urdu

🏅

ISMS 27001:2022

📋

ISO Accredited

🔒

HIPAA

All reports reviewed by DHA-Certified physicians